ONCOASSURE
Live / Registered — Registered (as of 01 Jul 2025)
What this means for you
Registered since 01 Jul 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Jul 2031: the §8 declaration of use).
Record
- Serial number
- 98407330
- Registration number
- 7847165
- Mark type
- Word mark
- Filed
- 15 Feb 2024
- Published for opposition
- 29 Oct 2024
- Registered
- 01 Jul 2025
- Next maintenance filing
- §8 declaration of use, due by 01 Jul 2031 (grace period to 01 Jan 2032)
- Attorney of record
- DANNA J. COTMAN
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic testing materials, namely, reagents, assays and biomarker reagents, for medical use but not for liquid biopsy assays featuring the sequencing of circulating nucleic acids.
Owner
- OncoAssure Limited, Dublin 4, IE
- OncoAssure Limited, Dublin 4, IE
- OncoAssure Limited, Dublin 4, IE
Board proceedings on this mark
- Opposition No. 91298611 — Caris MPI, Inc. v. OncoAssure Limited, filed 28 Apr 2025 (Terminated)
- Extension of Time to Oppose No. 98407330 — Caris MPI, Inc. v. OncoAssure Limited, filed 26 Nov 2024 (Terminated)
Prosecution history
- 01 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 10 Jun 2025 — TTAB RELEASE CASE TO TRADEMARKS
- 10 Jun 2025 — OPPOSITION TERMINATED NO. 999999
- 10 Jun 2025 — OPPOSITION DISMISSED NO. 999999
- 28 Apr 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 28 Apr 2025 — OPPOSITION INSTITUTED NO. 999999
- 26 Nov 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 29 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Oct 2024 — PUBLISHED FOR OPPOSITION
- 09 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Sept 2024 — EXAMINER'S AMENDMENT ENTERED
- 18 Sept 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 18 Sept 2024 — EXAMINERS AMENDMENT E-MAILED